UNSPSC 51151643: Hexocyclium

This classification denotes an antimuscarinic agent with the molecular formula C20H33N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LL3147PI1T. European Medicines Agency schedules hexocyclium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02515MIG. HEXOCYCLIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, HEXOCYCLIUM remains the US FDA Preferred Term for this commodity.

Hexocyclium bears US NLM identifiers UMLS ID C0062674 and NCI Concept Code C78074. SMILES: OC(C1CCCCC1)(CN1CC[N](CC1)(C)C)C1CCCCC1..

UNSPSC 51151643 Hexocyclium, a Commodity code, represents pharmaceutical products that state and local governments procure primarily through health and public safety agencies. Based on recent solicitation activity, the code encompasses naloxone (opioid antagonist medications) and related drug deactivation systems acquired to support community health and emergency response initiatives. These purchases typically involve quantity-based procurements with scheduled delivery requirements to specific agency facilities.

Seminole County, Florida, a county-level issuing body, posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with a response deadline of July 26, 2023. The procurement required quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs. The contract structure included an initial two-year term with a one-year renewal option, E-Verify compliance, drug-free workplace certification, and potential FEMA funding with associated federal regulatory requirements. The limited recent-opportunities activity on file for this code reflects narrow applicability; while the Seminole County opportunity demonstrates measurable demand for naloxone and drug deactivation systems within county health operations, the code shows sparse state and local procurement volume overall.